Spots Global Cancer Trial Database for adjuvant chemotherapy
Every month we try and update this database with for adjuvant chemotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Cytokine-induced Killer Cell Immunotherapy for Surgical Resected Stage III Colorectal Cancer Patients After Chemotherapy | NCT02280278 | Stage III Colon... | Radical surgery Adjuvant chemot... Cytokine-induce... | 18 Years - 70 Years | Sun Yat-sen University | |
| A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer | NCT00246597 | Anemia Breast Neoplasm... Hemoglobins Quality of Life Chemotherapy, A... | epoetin alfa | 18 Years - | Ortho Biotech Products, L.P. | |
| Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer | NCT00431080 | Breast Cancer | Docetaxel Paclitaxel Epirubicin Cyclophosphamid... 5-fluoruracil Granulocyte-col... | 18 Years - 75 Years | Hellenic Oncology Research Group | |
| Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1) | NCT03199989 | Adjuvant Chemot... | CapeOX（Capecita... Observation | 18 Years - 75 Years | Peking University Cancer Hospital & Institute | |
| the Role of ctDNA in Predicting the Recurrence Risk of Colorectal Cancer | NCT05131243 | Colorectal Canc... Colorectal Canc... | Chemotherapy ti... Chemotherapy ti... | 18 Years - | Fujian Cancer Hospital | |
| A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma | NCT00001300 | Sarcoma | doxorubicin ifosfamide mesna | - | National Institutes of Health Clinical Center (CC) | |
| Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the Breast | NCT01204437 | Breast Cancer | Epirubicin, Cyc... Cyclophosphamid... Capecitabine, N... | 65 Years - | German Breast Group | |
| CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCER | NCT03712956 | Breast Cancer | Caelyx® | 18 Years - 70 Years | European Institute of Oncology | |
| Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy | NCT04137640 | Breast Cancer | palbociclib com... epirubicin comb... | 18 Years - 70 Years | Shengjing Hospital | |
| Adjuvant Chemotherapy With FOLFOX in HCC Patients After Resection | NCT02738697 | Carcinoma, Hepa... | Adjuvant chemot... Follow-up | 18 Years - 75 Years | Sun Yat-sen University | |
| Perioperative Chemotherapy Combined With HIPEC for High-risk Advanced Gastric Cancer | NCT02960061 | Survival | Neoadjuvant che... D2 radical rese... Hyperthermic in... Adjuvant chemot... | 18 Years - 75 Years | Sixth Affiliated Hospital, Sun Yat-sen University | |
| Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal Carcinoma | NCT03413436 | Esophageal Canc... | Lobaplatin Cisplatin | - | Henan Cancer Hospital | |
| Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma | NCT02461043 | Esophageal Canc... | paclitaxel; cis... radiation | 18 Years - | ChineseAMS | |
| Oncological Benefits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With T3-4 Gastric Cancer Cyt- | NCT04595929 | Peritoneal Carc... Gastric Cancer | Staging laparos... 5-Fluorouracil Leucovorin Oxaliplatin Docetaxel Radical surgery PIPAC Adjuvant chemot... | 18 Years - 65 Years | St. Petersburg State Pavlov Medical University | |
| Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer | NCT00615602 | Breast Cancer | Docetaxel Trastuzumab Epirubicin Cyclophosphamid... 5-fluoruracil Granulocyte-col... Trastuzumab | 18 Years - 75 Years | Hellenic Oncology Research Group | |
| Adjuvant FEC Versus EP in Breast Cancer (MIG5) | NCT02450058 | Breast Cancer Chemotherapy, A... | 5-fluorouracil epirubicin cyclophosphamid... epirubicin paclitaxel | 18 Years - 70 Years | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | |
| Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1) | NCT03199989 | Adjuvant Chemot... | CapeOX（Capecita... Observation | 18 Years - 75 Years | Peking University Cancer Hospital & Institute | |
| CHEmotherapy and Cognitive Deterioration in Patients With Operable Breast Cancer: Impact of Cognitive Rehabilitation (CHEMOFOG) | NCT06435559 | Breast Cancer | Neurotablet® an... Neuropsychologi... | 18 Years - 75 Years | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | |
| Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer | NCT00146562 | Breast Cancer Stage I Breast ... Stage II Breast... | Darbepoetin Alf... Pegfilgrastim Paclitaxel Doxorubicin Cyclophosphamid... | 18 Years - | Dana-Farber Cancer Institute | |
| Circulating Tumor DNA Methylation Guiding Postoperative Adjuvant Chemotherapy in Stage III Colorectal Cancer | NCT06167967 | Colorectal Canc... | ctDNA methylati... standard treatm... | 18 Years - 75 Years | Sir Run Run Shaw Hospital | |
| Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC | NCT00452881 | Lung Cancer | gemcitabine Oxaliplatin Cisplatin | 18 Years - | National Cancer Center, Korea | |
| Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric Cancer | NCT00718913 | Gastric Cancer | Docetaxel Cisplatin Capecitabine Radiation Capecitabine | 18 Years - | Hellenic Oncology Research Group | |
| Study on Adjuvant Chemotherapy After Total Two-field Lymph Node Dissection of Thoracic Esophageal Squamous Cell Carcinoma | NCT04174079 | Thoracic Esopha... | chemotherapy | 18 Years - 75 Years | Sun Yat-sen University | |
| Acupuncture for QoL and Symptoms in Gastric Cancer During Adjuvant Chemotherapy | NCT04360577 | Stomach Neoplas... | acupuncture | 18 Years - 75 Years | Guangzhou University of Traditional Chinese Medicine | |
| Quantitative Nodal Burden as a Determinant Identifying Ampullary Adenocarcinoma Patients Benefiting From Adjuvant Chemotherapy | NCT06435767 | Ampullary Adeno... Chemotherapy Ef... | Adjuvant chemot... | 18 Years - 85 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| CHEmotherapy and Cognitive Deterioration in Patients With Operable Breast Cancer: Impact of Cognitive Rehabilitation (CHEMOFOG) | NCT06435559 | Breast Cancer | Neurotablet® an... Neuropsychologi... | 18 Years - 75 Years | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | |
| Physically Active During Cancer Treatment (FAKT) | NCT03885817 | Neoplasms, Colo... | Exercise traini... Standard follow... | 18 Years - | St. Olavs Hospital | |
| Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC | NCT05167604 | Carcinoma, Non-... Next-Generation... Chemotherapy, A... Neoplasm, Resid... Circulating Tum... | Adjuvants, Phar... | 18 Years - 70 Years | Tang-Du Hospital | |
| Quantitative Nodal Burden as a Determinant Identifying Ampullary Adenocarcinoma Patients Benefiting From Adjuvant Chemotherapy | NCT06435767 | Ampullary Adeno... Chemotherapy Ef... | Adjuvant chemot... | 18 Years - 85 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer | NCT00431080 | Breast Cancer | Docetaxel Paclitaxel Epirubicin Cyclophosphamid... 5-fluoruracil Granulocyte-col... | 18 Years - 75 Years | Hellenic Oncology Research Group | |
| A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA | NCT02363400 | Nasopharyngeal ... | MEP | 20 Years - | National Health Research Institutes, Taiwan | |
| Study Compare Adjuvant Chemotherapy, Chemoradiotherapy and Surgery Alone for pN1-2(pT1b-3N1-2M0) Esophageal Carcinoma | NCT04009265 | Esophageal Squa... | adjuvant treatm... | 18 Years - 75 Years | Fujian Medical University Union Hospital | |
| Perioperative Chemotherapy Combined With HIPEC for High-risk Advanced Gastric Cancer | NCT02960061 | Survival | Neoadjuvant che... D2 radical rese... Hyperthermic in... Adjuvant chemot... | 18 Years - 75 Years | Sixth Affiliated Hospital, Sun Yat-sen University | |
| A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF) | NCT00190515 | Colorectal Neop... | 5FU+l-leucovori... UFT+Leucovorin | 20 Years - 75 Years | Japan Clinical Oncology Group | |
| Trastuzumab Administered Concurrently or Sequentially to Anthracycline-containing Adjuvant Regimen for Breast Cancer | NCT01413828 | Breast Cancer | concurrent sequential | 18 Years - 70 Years | Peking Union Medical College Hospital | |
| Neoadjuvant Chemoradiotherapy vs. Chemotherapy With Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer | NCT01815853 | Gastric Cancer | Neoadjuvant Che... Neoadjuvant Che... R0 D2 Gastrecto... Adjuvant Chemot... | 18 Years - 75 Years | Sun Yat-sen University | |
| Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC | NCT00452881 | Lung Cancer | gemcitabine Oxaliplatin Cisplatin | 18 Years - | National Cancer Center, Korea | |
| A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer | NCT00246597 | Anemia Breast Neoplasm... Hemoglobins Quality of Life Chemotherapy, A... | epoetin alfa | 18 Years - | Ortho Biotech Products, L.P. | |
| Circulating Tumor DNA Methylation Guiding Postoperative Adjuvant Chemotherapy in Stage III Colorectal Cancer | NCT06167967 | Colorectal Canc... | ctDNA methylati... standard treatm... | 18 Years - 75 Years | Sir Run Run Shaw Hospital | |
| Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks | NCT05212454 | Breast Cancer Chemotherapy Ef... | Capecitabine | 18 Years - 70 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Neoadjuvant Pemetrexed, Carboplatin and Bevacizumab in Unresectable, Locally Advanced Lung Adenocarcinoma | NCT01588704 | Lung Cancer | Neoadjuvant Bev... | 18 Years - 65 Years | Sun Yat-sen University | |
| Neoadjuvant Pemetrexed, Carboplatin and Bevacizumab in Unresectable, Locally Advanced Lung Adenocarcinoma | NCT01588704 | Lung Cancer | Neoadjuvant Bev... | 18 Years - 65 Years | Sun Yat-sen University | |
| Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC | NCT03562637 | Triple Negative... | adagloxad simol... Globo H IHC Ass... Standard of car... | 18 Years - | OBI Pharma, Inc | |
| Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery | NCT03373058 | Epithelial Ovar... Fallopian Tube ... Primary Periton... | Hyperthermic In... cytoreductive s... adjuvant chemot... | 18 Years - 70 Years | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | |
| Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer | NCT00675259 | Breast Cancer | bevacizumab carboplatin nab-paclitaxel Surgery Adjuvant chemot... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer | NCT03858166 | Adjuvant Chemot... Ovarian Neoplas... Ovarian Cancer | PEG-rhG-CSF | 18 Years - 80 Years | Shandong University | |
| The Symphony Triple A Study: Using Symphony in Treatment Decisions Concerning Adjuvant Systemic Therapy | NCT02209857 | Breastcancer Invasive Breast... | 18 Years - | Diakonessenhuis, Utrecht | ||
| Quality of Life and Sexuality of Patients Over 65 Years Undergoing Adjuvant Treatment for Breast Cancer | NCT03946579 | Breast Cancer | self questionna... | 65 Years - | Centre Henri Becquerel | |
| OPTIMIzation of Treatment SElection and Follow up in Oligometastatic Colorectal Cancer | NCT04680260 | Colorectal Canc... Metastatic Canc... | Standard of car... Circulating tum... | 18 Years - | Aarhus University Hospital | |
| Apatinib for Resectable Colorectal Cancer | NCT03228043 | Apatinib Outcome, Fatal Colorectal Canc... Surgery Adjuvant Chemot... | Apatinib CAPEOX | 18 Years - 75 Years | Nanchong Central Hospital | |
| Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer | NCT02102438 | Breast Cancer HER-2 Positive ... | Trastuzumab Weekly Paclitax... Carboplatin | 65 Years - | Instituto do Cancer do Estado de São Paulo | |
| Impact of Adjuvant Chemotherapy in Patients With Colon Cancer | NCT03213444 | Colon Cancer Adjuvant Chemot... | adjuvant chemot... adjuvant chemot... | 30 Years - 75 Years | University of Sao Paulo General Hospital | |
| The Long-term Effect of D4 Lymphadenectomy for Gastric Cancer | NCT02423278 | Gastric Cancer Surgery Effects of Chem... | Radical Gastrec... Radical Gastrec... S-1+Oxaliplatin | 18 Years - 65 Years | First Affiliated Hospital, Sun Yat-Sen University | |
| Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers | NCT05194878 | Colon Cancer St... Colon Cancer St... | neoadjuvant che... Colectomy adjuvant chemot... | 18 Years - 75 Years | Sun Yat-sen University | |
| Apatinib for Resectable Colorectal Cancer | NCT03228043 | Apatinib Outcome, Fatal Colorectal Canc... Surgery Adjuvant Chemot... | Apatinib CAPEOX | 18 Years - 75 Years | Nanchong Central Hospital | |
| Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer | NCT04136782 | Breast Cancer | Albumin-bound p... Epirubicin comb... | 18 Years - 70 Years | Shengjing Hospital | |
| Neoadjuvant Chemoradiotherapy vs. Chemotherapy With Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer | NCT01815853 | Gastric Cancer | Neoadjuvant Che... Neoadjuvant Che... R0 D2 Gastrecto... Adjuvant Chemot... | 18 Years - 75 Years | Sun Yat-sen University | |
| Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer | NCT05735145 | Uterine Cervica... Chemoradiothera... Adjuvant Chemot... | paclitaxel comb... | 18 Years - 75 Years | Fourth Affiliated Hospital of Guangxi Medical University | |
| Adjuvant Chemotherapy for Biliary Tract Cancer After Curative Resection | NCT03779035 | Cholangiocarcin... Gall Bladder Ca... | Gemcitabine Capecitabine | 18 Years - | Tianjin Medical University Cancer Institute and Hospital | |
| Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy | NCT04137640 | Breast Cancer | palbociclib com... epirubicin comb... | 18 Years - 70 Years | Shengjing Hospital | |
| Trial of Adjuvant Chemotherapy for Gastric Cancer | NCT00296322 | Stomach Cancer | cisplatin, mito... | 18 Years - 69 Years | Asan Medical Center | |
| Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study | NCT04737551 | Resectable Panc... Adjuvant Chemor... Surgery | Follow-up only Adjuvant chemot... Adjuvant chemor... Adjuvant chemor... | 18 Years - 90 Years | Shanghai Zhongshan Hospital | |
| Effect of Acupuncture for QoL in Gastric Cancer Patients Undergoing Adjuvant Chemotherapy: a Pilot Study | NCT03753399 | Stomach Neoplas... | acupuncture | 18 Years - 75 Years | Guangzhou University of Traditional Chinese Medicine | |
| Adjuvant Chemotherapy in High Risk Stage II Colon Cancer | NCT04303429 | Stage II Colon ... Adjuvant Chemot... | FOLFOX/XELOX/Ca... | 18 Years - 75 Years | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | |
| Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer | NCT04927780 | Pancreatic Canc... Pancreatic Duct... Resectable Panc... | Leucovorin Calc... Fluorouracil Irinotecan Hydr... Oxaliplatin Resection | 18 Years - | Erasmus Medical Center | |
| S-1 Versus S-1 Plus Cisplatin as an Adjuvant Chemotherapy to Treat Gastric Cancer | NCT01426646 | Gastric Cancer | S-1 S-1 plus cispla... | 18 Years - 70 Years | Kyungpook National University Hospital | |
| Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or Trastuzumab | NCT02236806 | Breast Cancer Cardiotoxicity | Bisoprolol Ramipril Placebo | 18 Years - | Azienda Ospedaliero-Universitaria Careggi | |
| Development of Gourmet Healthy Cooking Workshop for Cancer Patients | NCT00364975 | Breast Cancer | gourmet cooking... | - | Hadassah Medical Organization | |
| A Phase II Study of S-1 Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer in Taiwan | NCT04070313 | Resected Pancre... Pancreatic Canc... Adjuvant Chemot... | S-1 | - | TTY Biopharm | |
| Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer | NCT00675259 | Breast Cancer | bevacizumab carboplatin nab-paclitaxel Surgery Adjuvant chemot... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients | NCT03448549 | Colorectal Canc... Adjuvant Chemot... | Oxaliplatin Tegafur，gimerac... Xeloda | 18 Years - | Peking University Cancer Hospital & Institute | |
| Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer | NCT02102438 | Breast Cancer HER-2 Positive ... | Trastuzumab Weekly Paclitax... Carboplatin | 65 Years - | Instituto do Cancer do Estado de São Paulo | |
| Is ENI Necessary For Patients With Thoracic Esophageal Cancer After Esophagectomy And With Pathological Stage Of T1-2,N+,M0 | NCT01398449 | Esophageal Squa... | Elective nodal ... Adjuvant chemot... | 18 Years - 70 Years | Fudan University | |
| Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB. | NCT02736552 | Gastric Cancer | S-1 for 6 month... S-1 for 1 year | 18 Years - 75 Years | Fudan University | |
| New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy | NCT04564157 | Non-Small Cell ... Adjuvant Chemot... | Carboplatin Paclitaxel Nivolumab | 18 Years - | Fundación GECP | |
| Surgery for Pancreatic Tumors and Collection of Tumor Tissue for Study | NCT00100321 | Pancreatic Neop... | 16 Years - | National Institutes of Health Clinical Center (CC) | ||
| Trastuzumab Administered Concurrently or Sequentially to Anthracycline-containing Adjuvant Regimen for Breast Cancer | NCT01413828 | Breast Cancer | concurrent sequential | 18 Years - 70 Years | Peking Union Medical College Hospital | |
| The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast Cancer | NCT02167932 | Breast Cancer Aging | Walk With Ease | 21 Years - 59 Years | UNC Lineberger Comprehensive Cancer Center | |
| A Longitudinal Study of Cancer-related Fatigue Among Colorectal Cancer Patients During Adjuvant Chemotherapy | NCT03013972 | ColoRectal Canc... | 20 Years - | Mackay Memorial Hospital | ||
| S-1-induced Lacrimal Drainage Obstruction | NCT01486472 | Gastric Cancer | S-1 | 18 Years - | Seoul National University Bundang Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
